obviously they see utility in their platform. perhaps this will springboard into other diseases so we are proactive, not reactive.
"Don't worry about the world coming to an end today. It's already tomorrow in Australia"
Recent DYAI News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2026 01:56:17 AM
- Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress • GlobeNewswire Inc. • 03/25/2026 08:51:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:14:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:13:15 PM
- Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices • GlobeNewswire Inc. • 03/16/2026 11:20:00 AM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 • GlobeNewswire Inc. • 03/11/2026 08:10:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 10:04:30 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2026 10:02:34 PM
- Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) • GlobeNewswire Inc. • 03/04/2026 12:20:00 PM
- Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone • GlobeNewswire Inc. • 03/02/2026 12:20:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:14:24 PM
- Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin • GlobeNewswire Inc. • 02/17/2026 12:25:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:12:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:11:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:10:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:08:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:07:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:05:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 11:04:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2025 09:00:40 PM
- Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets • GlobeNewswire Inc. • 12/17/2025 12:20:00 PM
- Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins • GlobeNewswire Inc. • 12/15/2025 12:20:00 PM
- Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 • ACCESS Newswire • 12/08/2025 02:00:00 PM
